Fundacion Instituto de Reumatologia Fernando Chalem

Bogotá 111211

0 studies enrolling now · 5 studies all time

What they study most

Rheumatoid Arthritis, Systemic Lupus Erythematosus

Studies at this site

• Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis — Completed
• Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease — Completed
• Effects of Abatacept in Patients With Early Rheumatoid Arthritis — Completed
• A Phase II Study of M2951 in SLE — Stopped early
• A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02). — Completed